Milestone Scientific Inc. (MLSS) shares climbed 5.44% in after-hours on Friday, June 25, 2021, and closed the week at $2.52 per share. Earlier, MLSS’s stock gained 16.59% to close Friday’s normal trading session at $2.39 per share. MLSS shares have fallen 2.45% over the last 12 months, and they have moved up 23.83% in the past week. Over the past three months, the stock has lost 30.92%, while over the past six months, it has declined 21.94%.
>> 7 Top Picks for the Post-Pandemic Economy <<
Let’s have a look at its recent news and developments.
When it comes to discovering hidden gems within the stock market, Stock Wire News has consistently provided invaluable insights. Stock Wire News invites you to explore their upcoming Wealth Building Report. This report will shine a spotlight on little-known companies with the potential for substantial growth in 2024, and it's completely FREE for a limited time.
Claim the free report now by clicking here and start discovering the hidden gems of the market
Sponsored
Medical sales team expansion
On June 23, 2021, Milestone Scientific Inc expanded its medical sales team by the appointment of Chet Trechock as VP of Sales Medical.
Mr Chet Trechock has more than 25 years of extensive experience in many reputable organizations around the globe, mostly focus on pain management, neurosurgery, neurology, and orthopedics.
Recent participation at an important conference
Milestone Scientific Inc recently participated at Best Ideas from the Buy-Side conference which held virtually on June 1st – 4th, 2021.
Read More
The company was presented by Chief Executive Officer and President of Milestone Scientific, Arjan Haverhals, and had one on one meetings with investors and analysts throughout the conference.
Recent financial results announcement
On May 17, 2021, Milestone Scientific Inc released its financial results for the first quarter ended March 31, 2021.
Q1 2021 financial highlights
- Milestone Scientific Inc earned a revenue of $2.9 million for Q1 2021 compared to $1.8 million for Q1 2020.
- The gross profit was $1.8 million for the first quarter ended March 31, 2021, compared to $1.3 million for Q1 2020.
- Total operating expenses were $2.79 million in Q1 2021 compared with $2.9 million in Q1 2020.
- MLSS had an operating loss of approximately $1.0 million in Q1 2021compared to approximately $1.6 million for the first quarter ended March 31, 2020.
- It suffered a net loss of $1.0 million, or $0.01 per share in Q1 2021 compared to a net loss of $1.6 million, or $0.03 per share, for the comparable period in 2020.
New CEO and CFO appointments
On May 13, 2021, the Board of Directors of Milestone Scientific Inc promoted Jan Adriaan (Arjan) Haverhals, President of the Company, to also serve as Chief Executive Officer of the company, effective May 19, 2021, after Leonard Osser announced his intention to resign as Interim Chief Executive Officer.
The company elected Leonard Osseras Vice Chairman of the Board of Directors of the Company, effective May 19, 2021.
Scott Kahn was also appointed as the new Chief Financial Officer, effective May 24, 2021. Mr. Kahn replaced Joseph D’Agostino who retired from Milestone Scientific in April 2021.
>> 7 Top Picks for the Post-Pandemic Economy <<
Conclusion
MLSS stock’s good performance on Friday has no grounds at the moment because we had no recent news or development which could justify its gain on Friday. there are high chances that MLSS will continue its positive momentum after the weekend as well.
